Biotech researching cell-reprogramming technology to reverse ageing.
| Date | Round | Amount |
|---|---|---|
| Sep 2021 | Funding round Altos Labs, a US cell-reprogramming biotech, raised $270M with backing reported from Jeff Bezos and Yuri Milner. | $270M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.